First subject dosed in Phase 1 clinical trial of EMB-001
29 May 2015 | By Victoria White
Embera NeuroTherapeutics has announced that the first subject has received the initial dose in a Phase 1 clinical trial evaluating EMB-001...
List view / Grid view
News
Presence of IGFBPs correlates with tumour-promoting effects of MMP9 in breast cancer
29 May 2015 | By Victoria White
A team of researchers has found that the presence of IGFBP-1 interacted with MMP9 to promote breast cancer tumour formation in mouse models...
Degenerating white matter may be early marker of Alzheimer’s disease
29 May 2015 | By Victoria White
Degeneration of the white matter of the brain may be an early marker of specific types of Alzheimer's disease, including early-onset Alzheimer's disease...
TSRI scientists win $2.2 million to expand study of IP6K1 to help develop new obesity therapies
28 May 2015 | By Victoria White
TSRI scientists have been awarded nearly $2.2 million to advance understanding of IP6K1 and develop innovative approaches for the treatment of obesity...
Dormant cancer cells can ‘wake up’ after decades
28 May 2015 | By Victoria White
Researchers have found genetic evidence that dormant cancer cells can avoid the effects of treatment only to ‘wake up’ many years later...
Blocking LOX enzyme could prevent breast cancer from spreading
28 May 2015 | By Victoria White
Scientists have identified an enzyme, LOX, that possibly holds the key to preventing secondary cancers in breast cancer patients...
Merozyne Therapeutics launches project to develop a treatment for patients with MDC1A
27 May 2015 | By Victoria White
Merozyne has started a project to develop a pharmaceutical treatment against laminin alpha2 chain-deficient congenital muscular dystrophy (MDC1A)...
Achilles’ heel of Ebola virus identified in new study
27 May 2015 | By Victoria White
An international team of scientists has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells...
An interview with Ben Busby, National Center for Biotechnology Information (NCBI)
26 May 2015 | By Oxford Global Conferences
In the run up to the Next Generation Sequencing USA Congress & co-located Single Cell Genomics and Transcriptomics USA Congress, Oxford Global Conferences interviewed Ben Busby, Genomics Outreach Coordinator, NCBI...
TSRI chemists devise inexpensive method for synthesising amines
26 May 2015 | By Victoria White
Chemists at The Scripps Research Institute (TSRI) have discovered a broad and strikingly inexpensive method for synthesising amines...
Eisai to promote clinical trial data disclosure for the advancement of science and medicine
26 May 2015 | By Victoria White
In order to promote transparency in clinical trial data disclosure, Eisai is making its clinical trial data available to researchers via an external website...
Anti-stroke drug Vinpocetine could be effective as a treatment for middle-ear infections
22 May 2015 | By Victoria White
Vinpocetine is an effective treatment for middle-ear infections, showing the ability to improve bacterial clearance and reduce hearing loss...
Janssen and Achillion enter into worldwide collaboration to combat Hepatitis C
22 May 2015 | By Victoria White
Achillion and Janssen have entered into a worldwide license and collaboration arrangement to develop and commercialise one or more of Achillion's HCV assets...
Eureka Therapeutics and Boehringer Ingelheim enter into antibody research agreement
22 May 2015 | By Victoria White
Eureka Therapeutics and Boehringer Ingelheim have entered into a research agreement for the discovery of novel therapeutic antibodies in oncology...
Scientists unveil ‘Rosetta Stone’ of prostate cancer
21 May 2015 | By Victoria White
Almost 90% of men with advanced prostate cancer carry genetic mutations in their tumours that could be targeted by either existing or new cancer drugs...
